JP2007516701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516701A5 JP2007516701A5 JP2006538829A JP2006538829A JP2007516701A5 JP 2007516701 A5 JP2007516701 A5 JP 2007516701A5 JP 2006538829 A JP2006538829 A JP 2006538829A JP 2006538829 A JP2006538829 A JP 2006538829A JP 2007516701 A5 JP2007516701 A5 JP 2007516701A5
- Authority
- JP
- Japan
- Prior art keywords
- saa
- fpr
- hiv
- wkymwvm
- peprotec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PRQROPMIIGLWRP-BZSNNMDCSA-N chemotactic peptide Chemical compound CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-BZSNNMDCSA-N 0.000 description 2
- 102100021145 fMet-Leu-Phe receptor Human genes 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
- 101710091342 Chemotactic peptide Proteins 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 101000818546 Homo sapiens N-formyl peptide receptor 2 Proteins 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 102100021126 N-formyl peptide receptor 2 Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51710403P | 2003-11-05 | 2003-11-05 | |
| US58072004P | 2004-06-21 | 2004-06-21 | |
| PCT/EP2004/013393 WO2005044292A2 (en) | 2003-11-05 | 2004-11-05 | Biomarkers of resistance to hiv-infections in humans and biological applications thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007516701A JP2007516701A (ja) | 2007-06-28 |
| JP2007516701A5 true JP2007516701A5 (enExample) | 2008-01-17 |
Family
ID=34576787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538829A Pending JP2007516701A (ja) | 2003-11-05 | 2004-11-05 | ヒトのｈｉｖ感染に対して抵抗性のバイオマーカーおよびその生物学的適用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070009926A1 (enExample) |
| EP (1) | EP1748789B1 (enExample) |
| JP (1) | JP2007516701A (enExample) |
| AT (1) | ATE493142T1 (enExample) |
| AU (1) | AU2004287205A1 (enExample) |
| BR (1) | BRPI0416240A (enExample) |
| CA (1) | CA2544972C (enExample) |
| CY (1) | CY1113088T1 (enExample) |
| DE (1) | DE602004030830D1 (enExample) |
| DK (1) | DK1748789T3 (enExample) |
| PL (1) | PL1748789T3 (enExample) |
| PT (1) | PT1748789E (enExample) |
| WO (1) | WO2005044292A2 (enExample) |
| ZA (1) | ZA200604550B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| US10545149B2 (en) * | 2008-10-06 | 2020-01-28 | Morehouse School Of Medicine | Detection of HIV-related proteins in urine |
| GB201002409D0 (en) * | 2010-02-12 | 2010-03-31 | Univ Nottingham | Methods |
| WO2012040623A2 (en) | 2010-09-24 | 2012-03-29 | The Brigham And Women's Hospital, Inc. | Nanostructured gels capable of controlled release of encapsulated agents |
| PL2970422T3 (pl) | 2013-03-15 | 2018-09-28 | F.Hoffmann-La Roche Ag | Polipeptydy IL-22 i białka fuzyjne IL-22 Fc i sposoby zastosowania |
| US10646548B2 (en) * | 2013-10-08 | 2020-05-12 | Georgia State University Research Foundation, Inc. | Compositions including IL-18 and IL-22 and their use in anti-viral therapies |
| CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
| WO2017181143A1 (en) | 2016-04-15 | 2017-10-19 | Generon (Shanghai) Corporation, Ltd. | Use of il-22 in treating necrotizing enterocolitis |
| CN113825495A (zh) * | 2018-10-11 | 2021-12-21 | 阿利维奥治疗学股份有限公司 | 用于智能释放的不可注射水凝胶调配物 |
| EP4106794A4 (en) | 2020-02-19 | 2024-03-20 | Evive Biotechnology (Shanghai) Ltd | METHOD FOR TREATING TRANSPLANT AND HOST DISEASE |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002516103A (ja) * | 1998-05-29 | 2002-06-04 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | インターロイキン２１およびインターロイキン２２ |
| US20010023070A1 (en) * | 1998-05-29 | 2001-09-20 | Reinhard Ebner | Interleukins-21 and 22 |
| US6939545B2 (en) * | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
| US20030170823A1 (en) * | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| GB0024442D0 (en) * | 2000-10-05 | 2000-11-22 | Isis Innovation | Genetic factors affecting the outcome of viral infections |
| AU2002240137A1 (en) * | 2001-01-30 | 2002-08-12 | University Of Iowa Research Foundation | Antiviral activities of primate theta defensins and mammalian cathelicidins |
-
2004
- 2004-11-05 PT PT04803279T patent/PT1748789E/pt unknown
- 2004-11-05 AT AT04803279T patent/ATE493142T1/de active
- 2004-11-05 EP EP04803279A patent/EP1748789B1/en not_active Expired - Lifetime
- 2004-11-05 BR BRPI0416240-4A patent/BRPI0416240A/pt not_active Application Discontinuation
- 2004-11-05 PL PL04803279T patent/PL1748789T3/pl unknown
- 2004-11-05 DE DE602004030830T patent/DE602004030830D1/de not_active Expired - Lifetime
- 2004-11-05 DK DK04803279.1T patent/DK1748789T3/da active
- 2004-11-05 CA CA2544972A patent/CA2544972C/en not_active Expired - Fee Related
- 2004-11-05 JP JP2006538829A patent/JP2007516701A/ja active Pending
- 2004-11-05 AU AU2004287205A patent/AU2004287205A1/en not_active Abandoned
- 2004-11-05 WO PCT/EP2004/013393 patent/WO2005044292A2/en not_active Ceased
-
2006
- 2006-05-05 US US11/381,811 patent/US20070009926A1/en not_active Abandoned
- 2006-06-02 ZA ZA2006/04550A patent/ZA200604550B/en unknown
-
2011
- 2011-03-28 CY CY20111100330T patent/CY1113088T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
| EP2949658A3 (en) | Peptides that specifically bind HGF receptor (cMet) and uses thereof | |
| EP2383285A3 (en) | Peptide Sequences and Compositions | |
| MXPA06003474A (es) | Agonistas de receptores de melanocortina. | |
| EA200700210A1 (ru) | ВАРИАНТЫ ОБЛАСТИ Fc | |
| DE602004025668D1 (de) | Methoden der verhinderung und behandlung der alzheimer'schen krankheit | |
| JP2006506942A5 (enExample) | ||
| WO2005016132A3 (en) | Diagnostics for sars virus | |
| WO2007048857A8 (es) | USO DE PÉPTIDOS INHIBIDORES DE TGF- βl EN LA PREPARACIÓN DE UN AGENTE MODULADOR DE LA RESPUESTA INMUNE | |
| JP2019533722A5 (enExample) | ||
| JP2008539252A5 (enExample) | ||
| WO2006113958A8 (en) | Affinity ligands | |
| MY140306A (en) | Corticotropin releasing factor receptor 2 agonists | |
| WO2005061532A8 (es) | Composiciones y procedimientos para detectar infección patógena | |
| JP2007510403A5 (enExample) | ||
| JP2022119899A5 (enExample) | ||
| JP2008521795A5 (enExample) | ||
| JP2020117504A5 (enExample) | ||
| DE60114829D1 (de) | Variable region des monoklonalen antikörpers gegen das hbv s-oberflächenantigen und für diese kodierendes gen | |
| ES2585185T3 (es) | Polipéptidos quiméricos y sus aplicaciones terapéuticas contra una infección por Flaviviridae | |
| JP2006523185A5 (enExample) | ||
| WO2007019865A3 (en) | Therapy with cd4 binding peptides and radiation | |
| WO2005121175A3 (en) | Env polypeptide complexes and methods of use | |
| JP2019038772A5 (enExample) | ||
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen |